Diabetic cardiology

Brian M. Frier, Miles Fisher0470018445, 9780470018446, 9780470516263, 9780470862049, 0470862041

With cardiovascular disease becoming the most common cause of death in people with diabetes, interest in the assessment and treatment of heart disease in these patients has been reawakened. This book examines developing topics from a largely cardiological perspective, covering both pharmacological and non-pharmacological interventions. 
The DIGAMI study on the use of intravenous insulin infusion at the time of myocardial infarction (MI) has stimulated a large number of discussion papers on the best treatment of MI in the diabetic patient. The UKPDS has shown that treatment of Type 2 diabetes does not reduce cardiovascular end-points significantly, but that aggressive treatment of blood pressure can do so. In addition, sub-group analysis from several large cardiovascular trials has shown that treatment with statins, anti-platelet therapy, ACE inhibitors and other drugs will also reduce cardiovascular events in people with diabetes. 

---

Table of contents :
Cover……Page 1
Diabetic Cardiology……Page 2
Contents……Page 6
List of Contributors……Page 10
Introduction……Page 12
1 Epidemiology of Vascular Disease in Diabetes……Page 14
2 Pathogenesis of Atherosclerosis and Vascular Disease in Type 2 Diabetes……Page 29
3 Coronary Heart Disease and Diabetes……Page 50
4 Diabetes and Acute Coronary Syndromes……Page 81
5 Diabetes, Left Ventricular Systolic Dysfunction and Chronic Heart Failure……Page 105
6 Diabetes and Hypertension……Page 147
7 Diabetes and Stroke / Transient Ischaemic Attacks……Page 187
8 Diabetes and Peripheral Arterial Disease……Page 211
9 Prevention of Cardiovascular Events in Diabetic Patients……Page 235
10 Prevention of Diabetes as a Means of Preventing Cardiovascular Disease……Page 252
11 Diabetes for Cardiologists……Page 270
Study Acronyms……Page 292
Index……Page 299